Despite major progress over the last 50 years (80% of young people with malignancy are disease free at 5 years after diagnosis), cancer remains the most common cause of death by disease beyond the age of one.
"There is a need to accelerate the process of evaluating innovative therapies and introducing them in standard cancer care in children and adolescents."
Gilles Vassal, ACCELERATE Chair
It guarantees the involvement of the four stakeholder groups (academia, patient advocates, industry and regulators) as equal partners
It Is patient-centred and problem-solving
It is international, having more than thousand experts and advocates having participated in its initiatives